CAR-T

Umoja secures $100m to advance CAR-T cell therapy pipeline Pharmaceutical Technology09:38Umoja T-Cells

The in vivo revolution: How Interius, Umoja, Allogene, and Vyriad are transforming CAR-T cell therapy Labiotech14:19Umoja T-Cells

CAR-NK cells offer safer, more accessible treatment for lymphoma News-Medical.Net11:28T-Cells FDA Cancer

A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours Pharmaceutical Technology15:07A2 Biotherapeutics Biotechnology Pharma

[Ash 2024 Roundtable ①] Korea, US experts debate barriers, future of CAR-T, bispecific antibodies in hematology Korea Biomedical Review01:00T-Cells Pennsylvania Schools

Astraveus achieves end-to-end CAR-T production for the first time in history Manufacturing Chemist11:42T-Cells Pharma

CAR-T warning for secondary malignancies: Warranted or not? Medpage Today14:06T-Cells FDA

Curocell's Anbal-cel wins orphan drug designation for treatment of relapsed or refractory LBCL Korea Biomedical Review05:17

CARsgen gets a win for CAR-T in solid tumours pharmaphorum11:55China Pharma Biotechnology

CAR-T cells carry memory of past antigen encounters News-Medical.Net02:01Colorado Schools T-Cells Cancer

CAR-T cells hold memories of past encounters ScienceDaily00:30Colorado Schools T-Cells Cancer

Startup of the year 2024- ImmunoACT BioSpectrum Asia06:22T-Cells Mumbai India

Startup of the year 2024- 'ImmunoACT- Emerging Leader in Cell & Gene Therapy' BioSpectrum Asia05:52T-Cells Mumbai India

Latest News

In the last 10 minutes

Three drug cocktail shows potential to boost CAR-T cancer therapy ScienceDaily13:04

In the last 2 hours

CAR-NK cells offer safer, more accessible treatment for lymphoma News-Medical.Net11:28

In the last 4 hours

Umoja secures $100m to advance CAR-T cell therapy pipeline Pharmaceutical Technology09:38

Yesterday

Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells Nature.com23:18 14-Jan-25

New cellular immunotherapy approach shows promise for B-cell lymphoma Newswise (Press Release)18:16 14-Jan-25

New drug cocktail enhances CAR-T cells for cancer treatment News-Medical.Net02:34 14-Jan-25

In the last 7 days

Cancer Immunotherapy Global Market Overview 2023-2030: Oncolytic Viral Therapies, Checkpoint… Business Wire (Press Release)14:43 13-Jan-25

CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an… PR Newswire (Press Release)13:50 13-Jan-25

A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours Pharmaceutical Technology15:07 10-Jan-25

The in vivo revolution: How Interius, Umoja, Allogene, and Vyriad are transforming CAR-T cell therapy Labiotech14:19 10-Jan-25

Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli… GlobeNewswire (Press Release)09:13 10-Jan-25

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as … PR Newswire (Press Release)09:02 10-Jan-25

A2 Biotherapeutics Closes $80 Million Series C Financing to Advance Clinical Development of Its … Business Wire (Press Release)14:07 9-Jan-25

Astellas calls it quits on early-stage lymphoma CAR-T following pipeline review FierceBiotech12:20 9-Jan-25

Astraveus achieves end-to-end CAR-T production for the first time in history Manufacturing Chemist11:42 9-Jan-25

[ASH 2024 Roundtable ①] Korea, US experts debate barriers, future of CAR-T, bispecific antibodies in hematology Korea Biomedical Review01:00 9-Jan-25

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire (Press Release)12:00 8-Jan-25

VaxCell-Bio wins global G-Rex Grant Korea Biomedical Review06:57 8-Jan-25

In the last month

Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T GlobeNewswire (Press Release)14:39 7-Jan-25

CARIBOU ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Caribou… GlobeNewswire (Press Release)02:08 7-Jan-25

CAR-T Warning for Secondary Malignancies: Warranted or Not? Medpage Today14:06 5-Jan-25

CARsgen gets a win for CAR-T in solid tumours pharmaphorum11:55 3-Jan-25

CAR-T Cell Therapy Market Research 2024-2025: Navigating the CAR-T Landscape, Major Players, Recent Approvals, and… GlobeNewswire (Press Release)09:13 3-Jan-25

CARsgen Claims First Clinical Win For CLDN 18.2 CAR-T In G/GEJ Adenocarcinoma Scrip Pharma Intelligence02:08 3-Jan-25

CAR-T cells carry memory of past antigen encounters News-Medical.Net02:01 3-Jan-25

CAR-T cells hold memories of past encounters ScienceDaily00:30 3-Jan-25

Startup of the year 2024- ImmunoACT BioSpectrum Asia06:22 2-Jan-25

Startup of the year 2024- 'ImmunoACT- Emerging Leader in Cell & Gene Therapy' BioSpectrum Asia05:52 2-Jan-25

CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 … PR Newswire (Press Release)13:54 31-Dec-24

CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of … PR Newswire (Press Release)13:53 30-Dec-24

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in… PR Newswire (Press Release)21:16 27-Dec-24

Curocell's Anbal-cel wins orphan drug designation for treatment of relapsed or refractory LBCL Korea Biomedical Review05:17 26-Dec-24

New BCMA-Directed Therapies Show Promise in Multiple Myeloma Medpage Today16:41 23-Dec-24

AIIMS, Delhi developing low cost adaptive cellular therapy for treatment of multiple myeloma The Hindu11:05 23-Dec-24

AIIMS doctors in process of developing low cost adaptive cellular therapy for treatment of multiple myeloma The Telegraph, Calcutta15:29 21-Dec-24

China Pioneers Innovative Drug Development with a Surge in CAR-T Cell and ADC Therapy Advancements GlobeNewswire (Press Release)14:34 20-Dec-24

'Hope' for Plymouth cancer patients as new 'life-saving' treatment made available Plymouth Live06:12 20-Dec-24

Qihan Biotech Announces Appointment of Carl June to Scientific Advisory Board Business Wire (Press Release)15:00 19-Dec-24

Immix Biopharma Announces Positive U.S. Clinical Data From First Four Patients in NEXICART-2 U.S. Trial of… GlobeNewswire (Press Release)14:39 19-Dec-24

Hemogenyx Pharmaceuticals partners with Kure.ai for ultrafast CAR-T manufacturing Proactive Investors (US)07:28 19-Dec-24

Hemogenyx Partners with Kure.ai for Ultrafast CAR-T Manufacturing TipRanks07:13 19-Dec-24

Car-T cell therapy for the treatment of adult high-grade gliomas Nature.com05:14 19-Dec-24

Revolutionary cancer treatment comes to Plymouth Totnes Times15:46 18-Dec-24

Inceptor Bio and GRIT Bio Announce Strategic Partnership to Advance IB-T101, a Next-Generation… PR Newswire (Press Release)13:01 18-Dec-24

BrightPath and Cellistic partner for clinical trial advancements of CAR-T cell therapy Clinical Trials Arena11:51 16-Dec-24

NKTR-255 shows positive results in lymphoma therapy Drug Target Review09:39 16-Dec-24

view more headlines

15 Jan 13:04

About our CAR-T news

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.